GLP-1 agonists could be given to millions with heart conditions to help them stay out of hospital and live longer
Weight loss drugs can reduce by half the risk of heart patients being hospitalised or dying early, according to the largest study of its kind.
The class of drugs, known as GLP-1 agonists, have been found to offer “dramatic benefits” to heart patients, significantly cutting their risk of falling seriously ill or dying prematurely from any cause.
